Literature DB >> 9082860

Validation of different methods to compare isovolumic cardiac function in isolated hearts of varying sizes.

H Strömer1, A Cittadini, G Szymanska, C S Apstein, J P Morgan.   

Abstract

Functional comparison of isolated hearts with different sizes has been difficult because function varies at different ventricular volumes. To date, no standard volume has been established. To determine the most accurate experimental approach, we tested five different methods to standardize volume in control hearts with different sizes but similar papillary muscle function and in hearts with concentric hypertrophy: intracardiac balloon volume (VB) = 120 microliters (M1). VB at diastolic pressure = 10 mmHg (M2) or diastolic wall stress = 4 kdyn/cm2 (M3), V1 = 25 microliters/100 g body weight (M4) and VB = 50% of volume at peak developed pressure (Vmax; M5). Systolic and diastolic functions of control groups were different using M1 and comparable using M2 or M5. M3 and M4 showed borderline significant differences. We concluded that M5 and M2 were suitable to compare function among hearts of different sizes. If diastolic compliance is of interest, as in concentric hypertrophy, parameter-volume curves should be normalized by Vmax to compare function at corresponding points of the Frank-Starling curve (e.g., at 50% of Vmax, M5).

Entities:  

Mesh:

Year:  1997        PMID: 9082860     DOI: 10.1152/ajpheart.1997.272.1.H501

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  6 in total

1.  Differential effect of troponin T mutations on the inotropic responsiveness of mouse hearts--role of myofilament Ca2+ sensitivity increase.

Authors:  Syevda G Sirenko; James D Potter; Björn C Knollmann
Journal:  J Physiol       Date:  2006-06-15       Impact factor: 5.182

2.  Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats.

Authors:  Yoshiaki Takewa; Elie R Chemaly; Miyako Takaki; Li Fan Liang; Hongwei Jin; Ioannis Karakikes; Charlotte Morel; Yoshiyuki Taenaka; Eisuke Tatsumi; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-06       Impact factor: 4.733

3.  Androgen receptor independent cardiovascular action of the antiandrogen flutamide.

Authors:  Radu Iliescu; Luciana A Campos; Wolfgang-Peter Schlegel; Ingo Morano; Ovidiu Baltatu; Michael Bader
Journal:  J Mol Med (Berl)       Date:  2003-06-12       Impact factor: 4.599

4.  Cardiac dysfunction in adipose triglyceride lipase deficiency: treatment with a PPARα agonist.

Authors:  G Wölkart; A Schrammel; K Dörffel; G Haemmerle; R Zechner; B Mayer
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

5.  Metformin prevents the development of chronic heart failure in the SHHF rat model.

Authors:  Antonio Cittadini; Raffaele Napoli; Maria Gaia Monti; Domenica Rea; Salvatore Longobardi; Paolo Antonio Netti; Marion Walser; Mariateresa Samà; Gianluca Aimaretti; Jörgen Isgaard; Luigi Saccà
Journal:  Diabetes       Date:  2012-02-16       Impact factor: 9.461

6.  Protective Effects of TRPV1 Activation Against Cardiac Ischemia/ Reperfusion Injury is Blunted by Diet-Induced Obesity.

Authors:  Beihua Zhong; Shuangtao Ma; Donna H Wang
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2020
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.